LBRX vs LYB · $803.4M cap vs P/E 21, rev $16.37B
LB Pharmaceuticals Inc Common Stock (LBRX) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company listed on NASDAQ.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
LBRX does not have a complete income-statement cache yet.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
LBRX currently screens at market cap $803.4M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the LBRX and LYB stock pages for the full models.
Not investment advice.